Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
818.00    51.00 (6.65%)
Bid:
818.50
Ask:
824.00
Spread: 5.50 (0.672%)
Market Cap: £942.12m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Trading Update

4 Sep 2019 07:00

RNS Number : 7021K
Kainos Group plc
04 September 2019
Ā 

4 September 2019

Kainos Group plc

("Kainos" or "the Company")

Trading Update

Ā 

Kainos, a leading UK-based provider of digital services and platforms, today issues a trading update for the period from 1 April 2019 to date. The Company expects results for the full year ending 31 March 2020 to be in line with current market expectations.

Ā 

The Group has delivered a solid Digital Services performance with positive momentum across government, healthcare and commercial clients. Digital Transformation has made progress within the Commercial sector whilst continuing to be a key supplier in the UK Government's digital transformation programme. In relation to the latter, the Group remains cautious about public sector spending in the current political environment.

Ā 

In Workday Services, the Group continues to benefit from an increasing book of business in continental Europe and North America following geographic expansion. Digital Platforms growth has been driven by Smart, our Workday automated testing platform, where we have continued to win new clients and drive very strong growth.

Ā 

The announcement of Kainos' results for the six months ended 30 September 2019 will be made on Monday 11 November 2019.

Ā 

For further information, please contact:

Ā 

Kainos

via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Ā 

Investec Bank plc

Patrick Robb / Sebastian Lawrence

+44Ā 20 7597 5970

Canaccord Genuity

+44 20 7523 4606

Simon Bridges

Ā 

FTI Consulting LLP

+44 20 3727 1000

Matt Dixon / Harry Staight

Ā 

Ā 

About Kainos

KainosĀ Group plc is a UK-headquartered provider of Digital Services and Digital Platforms.Ā 

Ā 

The Group's Digital Services include full lifecycle development and support ofĀ customisedĀ Digital Services for government and commercial customers.Ā KainosĀ is also the leading European partner for Workday, Inc. ('Workday'), responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.Ā 

Ā 

The Group's Digital Platforms compriseĀ specialisedĀ digital platforms in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market-leading product for theĀ digitisationĀ of patient notes in the Acute sector of the NHS.

Ā 

Kainos has over 1,470Ā people across 12 offices in Europe and North America.Ā Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Ā 
END
Ā 
Ā 
TSTPMMPTMBJJMLL
Date   Source Headline
20th Sep 20183:15 pmRNSAGM Statement
14th Sep 20184:06 pmRNSHolding(s) in Company
5th Sep 20187:00 amRNSTrading Update
23rd Aug 20183:40 pmRNSTotal Voting Rights
8th Aug 20182:21 pmRNSDirector/PDMR Shareholding
8th Aug 20182:20 pmRNSDirector/PDMR Shareholding
31st Jul 20183:00 pmRNSAnnual Report and Notice of AGM
24th Jul 20185:41 pmRNSTotal Voting Rights
24th Jul 20183:57 pmRNSDirector/PDMR Shareholding
13th Jul 20187:00 amRNSHolding(s) in Company
4th Jul 20184:51 pmRNSKainos Director/PDMR Shareholding
3rd Jul 201811:54 amRNSKainos Director/PDMR Shareholding
26th Jun 20187:00 amRNSCapital Markets Day
25th Jun 20181:17 pmRNSDirector's Declaration
29th May 20187:00 amRNSPreliminary Results
24th May 20183:08 pmRNSBoard Committee Membership
16th Apr 20187:25 amRNSTrading Update
23rd Mar 20181:06 pmRNSNotification Of Major Holding(s)
23rd Mar 20189:00 amRNSDirector Declaration
22nd Mar 20185:45 pmRNSHolding(s) in Company
23rd Jan 20188:00 amRNSKainos advances digital healthcare transformation
27th Nov 20177:00 amRNSInterim Results
24th Oct 20178:00 amRNSKainos expands its Workday operations in Europe
28th Sep 201711:32 amRNSResult of AGM
4th Sep 20177:00 amRNSTrading Update
17th Aug 20174:32 pmRNSHolding(s) in Company
31st Jul 20173:08 pmRNSAnnual Report 2017 and Notice of AGM
11th Jul 201711:01 amRNSDirector/PDMR shareholdings
6th Jul 20177:00 amRNSFirst Irish customer for Kainos Evolve
3rd Jul 20174:29 pmRNSDirector/PDMR Shareholding
29th Jun 201712:33 pmRNSHolding(s) in Company
30th May 20177:00 amRNSPreliminary Results
12th Apr 20177:00 amRNSTrading Update
27th Mar 201712:01 pmRNSHolding(s) in Company
6th Mar 201710:00 amRNSKainos expands its Workday services in Europe
28th Nov 20167:00 amRNSInterim Results
14th Nov 20167:00 amRNSAppointment of Joint Corporate Broker
2nd Nov 20167:00 amRNSNotice of Results
22nd Sep 20161:45 pmRNSResult of AGM
6th Sep 20167:00 amRNSTrading Update
29th Jul 20165:00 pmRNSAnnual Report 2016 and Notice of AGM
21st Jul 20165:47 pmRNSAward of Shares under SIP and Directors' Dealings
30th Jun 20165:10 pmRNS2016 LTIP Awards - Replacement
30th Jun 20164:25 pmRNS2016 LTIP Awards
13th Jun 20162:27 pmRNSDirector/PDMR Shareholding
9th Jun 20168:00 amRNSKainos appoints new Commercial Client Director
31st May 20167:00 amRNSPreliminary Results
3rd May 20167:00 amRNSNotice of Results
19th Apr 20167:00 amRNSCapital Markets Day
31st Mar 20164:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.